Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jul 3, 2025

8.45USD+1.930%(+0.16)13,376

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 3, 2025 8:00:30 AM EDT

8.60USD+3.770%(+0.31)1,022

After-hours

Jun 30, 2025 4:53:30 PM EDT

7.60USD+1.740%(+0.13)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

7.16M

Industry

Biotechnology

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

27,526

Avg. Vol. 30 Day

40,890

Employees

Market Cap

7,160,787

Shares Out.

833,619

On/Off Exchange

47%/53%

6 Month Beta

1.19

1 Year Beta

1.39

2 Year Beta

1.65

3 Year Beta

1.11

52 Week Low

6.15

52 Week High

905.52

SMA50

8.57

SMA200

182.01

1 Week

+7.78%

1 Month

+18.98%

3 Month

-33.05%

6 Month

-91.21%

1 Year

-98.78%

2 Year

-99.99%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $8.45, and today's volume is 13,376. RNAZ is up 1.930% today. The 30 day average volume is 40,890. RNAZ market cap is 7.16M with 833,619 shares outstanding.

.dark-mode .vPr0S1{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .vPr0S1{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ